193 related articles for article (PubMed ID: 30202940)
1. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation.
Svrcek M; Borralho Nunes P; Villanacci V; Beaugerie L; Rogler G; De Hertogh G; Tripathi M; Feakins R;
J Crohns Colitis; 2018 Nov; 12(12):1486-1498. PubMed ID: 30202940
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology.
Matkowskyj KA; Chen ZE; Rao MS; Yang GY
Arch Pathol Lab Med; 2013 Mar; 137(3):338-50. PubMed ID: 23451745
[TBL] [Abstract][Full Text] [Related]
3. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
5. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
[TBL] [Abstract][Full Text] [Related]
6. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
Yang GY; Taboada S; Liao J
Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
10. IBD-related carcinoma and lymphoma.
Claessen MM; Siersema PD; Vleggaar FP
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
[TBL] [Abstract][Full Text] [Related]
11. [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].
Hirsch D
Pathologe; 2019 Dec; 40(Suppl 3):232-238. PubMed ID: 31811372
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
Goel GA; Kandiel A; Achkar JP; Lashner B
Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cells implicated in neoplasia development in idiopathic inflammatory bowel disease.
Hashash JG; Hartman DJ
Cell Immunol; 2019 Sep; 343():103720. PubMed ID: 29221690
[TBL] [Abstract][Full Text] [Related]
15. Evolving endoscopic strategies for detection and treatment of neoplastic lesions in inflammatory bowel disease.
Murthy SK; Kiesslich R
Gastrointest Endosc; 2013 Mar; 77(3):351-9. PubMed ID: 23317581
[TBL] [Abstract][Full Text] [Related]
16. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.
Axelrad JE; Lichtiger S; Yajnik V
World J Gastroenterol; 2016 May; 22(20):4794-801. PubMed ID: 27239106
[TBL] [Abstract][Full Text] [Related]
18. Mucins in inflammatory bowel diseases and colorectal cancer.
Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
20. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
